Antibody discovery with LabGenius' James Field

What's Next
06/06/2024 43 min
Antibody discovery with LabGenius' James Field

Listen "Antibody discovery with LabGenius' James Field"

Descargar episodio

Episode Synopsis

What do synthetic biology, machine learning and robotics have in common? James Field, CEO and founder of LabGenius, explains how his company is integrating bleeding-edge technologies from across these fields to discover the next-generation therapeutic antibodies. And change the way we approach drug discovery.  Find out more about Labgenius here and follow them on LinkedInFind Balderton Capital here and follow us on LinkedIn 

More episodes of the podcast What's Next

Can European Tech Hold the Line in Ukraine? | Florian Seibel, Quantum Systems 03/12/2025
Will the UK Lead the Next Energy Revolution? | Alan Chang, Fuse 26/11/2025
Can the UK Become a Global AI Leader? Meryem Arik | Doubleword 19/11/2025
What Comes After the AI Gold Rush | Marvin Purtorab, Convergence (Salesforce) 12/11/2025
How ZOE Is Turning Science Into a Startup | Jonathan Wolf, ZOE 05/11/2025
Building Europe’s Answer to SpaceX | Hélène Huby, The Exploration Company 29/10/2025
Barney Hussey-Yeo | Building AI with an attitude | Cleo 22/10/2025
Transforming business processes with generative AI with Writer's May Habib 01/08/2024
Government and deeptech with IQ Capital's Jonno Evans 25/07/2024
The future of energy: small modular nuclear reactors with Blue Energy's Jake Jurewicz 18/07/2024
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA